𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo

✍ Scribed by E Walter; R Keist; B Niederöst; I Pult; H E Blum


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
406 KB
Volume
24
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


For the systematic analysis of various clinical and molecular aspects of hepatitis B virus (HBV) infection, an experimental small animal system of HBV infection would be a great advance. The susceptibility to HBV infection, therefore, of hepatocytes from the tree shrew species tupaia belangeri was studied in vitro and in vivo. Primary hepatocytes isolated from livers of tupaias can be reproducibly infected with HBV. In vitro infection results in viral DNA and RNA synthesis in hepatocytes and secretion hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg) into culture medium. Tupaias can also be infected with HBV in vivo, resulting in viral DNA replication and gene expression in tupaia livers. Similar to acute, self-limited hepatitis B in humans HBsAg is rapidly cleared from serum, followed by seroconversion to anti-HBe and anti-HBs. These data clearly tht HBV is infectious to tupaia hepatocytes in vitro and transiently in vivo. Tupaias, therefore, may become a useful model for the experimental analysis of various molecular and clinical aspects of HBV infection, including the significance of HBV quasispecies, the steps involved in hepatocarcinogenesis as well as the evaluation of various antiviral strategies.


📜 SIMILAR VOLUMES


Hepatitis B virus mutations associated w
✍ Thomas F. Baumert; Chun Yang; Peter Schürmann; Josef Köck; Christian Ziegler; Ca 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 451 KB 👁 1 views

Hepatitis B virus (HBV) core promoter mutations have been implicated in the pathogenesis of fulminant hepatitis B. Due to the limited availability of primary human hepatocytes, the functional characterization of HBV mutants has been performed predominantly in transformed cells, which may not represe

Leucocyte hepatitis B virus DNA in acute
✍ F. Davison; G. J. M. Alexander; Ch. Anastassakos; E. A. Fagan; Roger Williams 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB 👁 1 views

In the present study we have investigated 53 patients with a spectrum of acute and chronic hepatitis B virus (HBV) infection for the presence of leucocyte HBV-DNA with the aid of molecular techniques. HBV-DNA was detected in peripheral blood mononuclear cells of 31 of 45 (69%) of chronic HBsAg carri

Hepatitis A Infection in Chronic Carrier
✍ Reinhart Zachoval; Michael Roggendorf; Friedrich Deinhardt 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 441 KB 👁 2 views

By routine screening for serologic markers of hepatitis A and B in patients with acute hepatitis, 30 chronic carriers of hepatitis B virus with serologic evidence of acute hepatitis A and two patients with simultaneous acute infection with hepatitis A virus and hepatitis B virus were detected. For

Acyclovir in chronic hepatitis B virus i
✍ Geoffrey M. Dusheiko 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB 👁 2 views

In a previous study a partial inhibition of viral replication was observed in HBeAg-positive patients after acyclovir (ACV) treatment. To assess those results and to evaluate different treatment regimens, a randomized controlled trial with ACV given at 45 mg/kg/day by continuous infusion (in 5 pati

AFP in chronic hepatitis B virus infecti
✍ Yun-Fan Liaw; Anna Lok 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

to be controlled for in comparing immunoprophylactic approaches. At present, DNA polymerase activity or HBV DNA is useful for estimating the level of exposure. In an editorial in this issue, Dr. Dienstag pointed out difficulties in comparing the results of two immunoprophylactic regimens conducted a